Asymptomatic Carotid Stenting Demands Strict Safety Evidence – TCT Debate
This article was originally published in The Gray Sheet
Executive Summary
The morbidity and mortality rate for carotid stenting in asymptomatic patients must drop below 1% before the procedure should become standard of care for that population, Christopher Zarins, MD, Stanford University argued Oct. 17 at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in Washington, D.C